TGFB1 and neoplasm: Tumor cell-derived interleukin-6, interleukin-1 and TGF-β can drive T cell differentiation towards a Th17 secretory helper cell phenotype that can induce RANKL production and osteoclasts activation via interleukin-17 production [30].